Royal College of Surgeons in Ireland
Browse

The gut microbiome associated with LGI1-antibody encephalitis

Download (3.03 MB)
journal contribution
posted on 2025-10-22, 08:55 authored by Edmund GilbertEdmund Gilbert, Sophie Binks, Valentina Damato, Christopher Uy, Paula Colmenero, Mark KellyMark Kelly, Mohamed Ibrahim Khalil, Marcus O'Brien, Marcus J Claesson, John F Cryan, Norman DelantyNorman Delanty, Sarosh R Irani, Gianpiero CavalleriGianpiero Cavalleri
<p dir="ltr"><b>Objective:</b><b> </b>Autoimmune encephalitis is a cause of brain inflammation characterized by auto-antibodies, which target cell surface neuronal proteins and lead to neuronal dysfunction. The most common form is associated with auto-antibodies to leucine-rich glioma-inactivated 1 (LGI1) protein, the presentation of which includes frequent focal seizures. The exact cause of these auto-antibodies remains unknown, but established predispositions include overrepresented human leukocyte antigen (<i>HLA</i>) alleles. Yet, these <i>HLA</i> alleles are themselves common in the healthy ancestry-matched population. One potential etiological hypothesis is that an environmental trigger, such as the gut microbiome, interacts with a genetically predisposed individual.</p><p dir="ltr"><b>Methods:</b><b> </b>To investigate this, we studied 42 patients with LGI1-antibody encephalitis (LGI1-Ab-E) and 27 familial/environmentally matched controls, and performed metagenomic shotgun sequencing, to describe the compositional and functional differences in the gut microbiome.</p><p dir="ltr"><b>Results:</b><b> </b>We observed that LGI1-Ab-E gut microbiomes exhibited a significant reduction in the ratio of Firmicutes (or Bacillota) and Bacteroidetes phyla, which is associated with the dosage of HLA susceptibility allele count in patients with LGI1-Ab-E. Furthermore, we identified differences in functional gene profiles in the gut microbiome that led to a reduction of neuroinflammatory protective short-chain fatty acids (SCFAs) in LGI1-Ab-E patients.</p><p dir="ltr"><b>Significance:</b><b> </b>Taken together, our results suggest that a compositional shift in the gut microbiome of LGI1-Ab-E associates with a neuroinflammatory state, possibly through the reduction of SCFA production. Our study highlights the potential of the gut microbiome to explain some of the complex condition and unravel etiological questions. Validation studies with greater sample sizes are recommended.</p>

Funding

Funder: Medical Research Charities Group | Grant ID: MRCG‐2018‐005

The immunobiology of autoantibody-mediated diseases of the central nervous system.

Wellcome Trust

Find out more...

Medical Research Charities Group. Grant Number: MRCG-2018-005

FutureNeuro

Science Foundation Ireland

Find out more...

Characterisation of autoantigen-specific human B cells in central nervous system autoantibody-mediated diseases

Medical Research Council

Find out more...

National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)

History

Related Materials

Department/Unit

  • School of Pharmacy and Biomolecular Sciences
  • FutureNeuro Centre

Research Area

  • Genomics and Personalised Medicine
  • Neurological and Psychiatric Disorders
  • Digital Medicine and Healthcare Data

Data Availability Statement

The raw metagenomic sequence data will be made accessible on the European Genome-Phenome Archive (EGA) upon publication, the details of which can be found at the project's github page: https://github.com/FutureNeuroIE/le-microbiome-2025.

Comments

The original article is available at https://onlinelibrary.wiley.com/

Published Citation

Gilbert E, et al. The gut microbiome associated with LGI1-antibody encephalitis. Epilepsia. 2025.

Publication Date

6 August 2025

PubMed ID

40768327

Publisher

John Wiley & Sons, Inc

Version

  • Published Version (Version of Record)